Carbapenems: seizure risk, allergy, valproate and stewardship

Understand why carbapenems are kept in reserve

Carbapenems kill bacteria by disrupting cell wall synthesis, like other beta-lactams, but cover a very broad range of organisms. That breadth makes them valuable for serious infections and organisms resistant to other agents. Overuse drives carbapenem resistance, which leaves very few treatment options, so labels direct use only for proven or strongly suspected bacterial infections.

Nurses support stewardship by obtaining ordered cultures before the first dose when this does not delay urgent treatment, giving doses on time, and prompting review when culture results return. A narrower antibiotic may be appropriate once the organism is known. Carbapenems do nothing for viral illness, and patients should understand why the course is completed as prescribed.

Carbapenems are given by injection, mostly intravenously, and some, such as ertapenem, may be given intramuscularly. Ertapenem is also used to prevent infection after colorectal surgery. Check the route, compatibility and infusion time against the pharmacy instructions, and monitor the IV site for redness or irritation during each dose.

Assess allergy history carefully before the first dose

Serious and occasionally fatal hypersensitivity reactions, including anaphylaxis, can occur. Carbapenems are contraindicated after a previous serious reaction to a carbapenem, and cross-reactivity with other beta-lactams such as penicillins and cephalosporins is possible. Ask what happened with each previous reaction rather than accepting the word allergy alone.

Report a history of severe reactions to any beta-lactam before giving the drug, and follow local guidance on allergy assessment. Observe closely during the first infusion. Hives, wheeze, throat tightness or hypotension require stopping the infusion, calling for help and following the anaphylaxis protocol.

Reduce seizure risk and catch the valproate interaction

Seizures and other neurological effects have been reported, most often in patients with existing brain disorders such as a history of seizures or brain lesions, and in those with impaired kidney function where the drug can accumulate. Doses are adjusted for renal function, so check creatinine trends and report declining urine output. Seizure precautions are reasonable for higher-risk patients.

Carbapenems can sharply reduce valproic acid levels, risking breakthrough seizures, and the meropenem label states this combination is generally not recommended. If a patient on valproate is prescribed a carbapenem, raise it with the prescriber and pharmacist before the first dose, because increasing the valproate dose may not overcome the interaction.

Watch for C. difficile and other adverse effects

Broad-spectrum antibiotics disrupt normal gut flora and can lead to C. difficile infection, which may cause watery or bloody stools and severe colitis. It can appear during treatment or up to two months or more afterwards. Report frequent watery stools, abdominal pain or fever, apply contact precautions as per local policy and avoid giving antidiarrhoeal medicines without prescriber review.

Other effects include headache, nausea, diarrhoea and phlebitis or injection-site reactions. Low platelets have been seen in patients with renal impairment, so report unusual bruising or bleeding. Teach patients and families that late-onset diarrhoea after discharge still needs reporting, and that the antibiotic history matters to the team assessing it.

Work a hypothetical interaction question

Imagine a hypothetical patient with epilepsy, well controlled on valproate, who is admitted with a complicated urinary infection. Meropenem is newly prescribed. Options include giving the first dose and monitoring for seizures, giving it and asking for a valproate level tomorrow, or holding the dose and contacting the prescriber and pharmacist about the interaction. The last option is strongest.

Giving the drug and watching accepts a predictable loss of seizure control. Measuring a level later reacts after the harm is underway. The prescriber may choose an alternative antibiotic or adjust anticonvulsant therapy; the nurse's role is to identify the conflict promptly, communicate it clearly and document the discussion, while ensuring the infection is not left untreated.

Sources and further reading

DailyMed: Meropenem injection label. Hypersensitivity and beta-lactam cross-reactivity, seizure risk factors, valproic acid interaction, C. difficile, renal adjustment, thrombocytopenia and stewardship.

MedlinePlus: Meropenem Injection. Carbapenem class, seizure history and kidney disease precautions, late diarrhoea up to two months, side effects and completing the course.

MedlinePlus: Ertapenem Injection. Ertapenem as a carbapenem, beta-lactam allergy, seizure and kidney precautions, severe diarrhoea and completing the course.

MedlinePlus: Imipenem and Cilastatin Injection. Imipenem-cilastatin as a carbapenem with seizure, brain lesion and kidney disease precautions.